Cargando…
195 The Impact of Administration of Leukotriene Receptor Antagonists, Pranlukast-EK to Infants with Bronchial Asthma
BACKGROUND: Bronchial asthma develops by the age of 3 years frequently in childhood in industrialized countries. Pranlukast hydrate, leukotriene receptor antagonists, has been shown to be clinically effective for the treatment of hypersensitivity and childhood asthma. The generic drugs for PLK were...
Autores principales: | Ogawa, Norifumi, Mikami, Kentaro, Sato, Masahiko, Mezawa, Kenniti, Iwata, Satoshi, Takazawa, Reiko, Oshiba, Akihiro, Hoshioka, Akira, Noma, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization Journal
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512954/ http://dx.doi.org/10.1097/01.WOX.0000411952.04837.57 |
Ejemplares similares
-
74 Analysis of IGE, IGE Rast Value and Prick Test in Wheat or Hen's Egg-Allergy Infants Treated with Slow Specific Oral Tolerance Induction Therapy
por: Noma, Takeshi, et al.
Publicado: (2012) -
170 Combination of a Nasal Antihistamine Olopatadine and A Leukotriene Receptor Antagonist Montelukast Sodium for the Treatment of Seasonal Allergic Patients not Currently Controlled on Monotherapy Intranasal Antihistamine or a Leukotriene Receptor Antagonist
por: Nsouli, Safa
Publicado: (2012) -
336 The Leukotriene C4 Synthase (A-444C) Promoter Polymorphism in Venezuelan Individuals with Asthma
por: Quintero, Ingrid Quintana, et al.
Publicado: (2012) -
319 Bronchial Hyperresponsiveness in Obese Adolescents
por: Ramírez, Gabriela, et al.
Publicado: (2012) -
525 Bronchial Hyperresponsiveness in Children with Suggestive Asthma Symptoms
por: Sanchez-Garcia, Silvia, et al.
Publicado: (2012)